
08/01/2025
This randomized clinical trial assesses the efficacy of Tongxinluo, a traditional Chinese medicine compound, vs placebo in improving clinical outcomes in patients with ST-segment elevation myocardial infarction.
A leading innovative company.
Shijiazhuang
Be the first to know and let us send you an email when Yiling Pharma posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Send a message to Yiling Pharma: